The Securities and Exchange Commission has not necessarily reviewed the information in this filing and has not determined if it is accurate and complete. | |||||||||||||||||||||
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 13F FORM 13F INFORMATION TABLE |
|
COLUMN 1 | COLUMN 2 | COLUMN 3 | COLUMN 4 | COLUMN 5 | COLUMN 6 | COLUMN 7 | COLUMN 8 | ||||
VALUE | SHRS OR | SH/ | PUT/ | INVESTMENT | OTHER | VOTING AUTHORITY | |||||
NAME OF ISSUER | TITLE OF CLASS | CUSIP | (x$1000) | PRN AMT | PRN | CALL | DISCRETION | MANAGER | SOLE | SHARED | NONE |
4D MOLECULAR THERAPEUTICS INC | COM | 35104E100 | 1,800,704 | 104,753 | SH | SOLE | 104,753 | 0 | 0 | ||
AADI BIOSCIENCES INC | COM | 00032Q104 | 13,389,670 | 1,849,402 | SH | SOLE | 1,849,402 | 0 | 0 | ||
ACLARIS THERAPEUTICS | COM | 00461U105 | 985,686 | 121,840 | SH | SOLE | 121,840 | 0 | 0 | ||
ALKERMES PLC | SHS | G01767105 | 893,313 | 31,689 | SH | SOLE | 31,689 | 0 | 0 | ||
APELLIS PHARMACEUTICALS INC | COM | 03753U106 | 19,161,380 | 290,500 | SH | SOLE | 290,500 | 0 | 0 | ||
ARGEN SE | SPONSORED ADR | 04016X101 | 3,574,533 | 9,594 | SH | SOLE | 9,594 | 0 | 0 | ||
BELLUS HEALTH INC | COM NEW | 07987C204 | 4,554,000 | 632,500 | SH | SOLE | 632,500 | 0 | 0 | ||
CELLDEX THERAPEUTICS INC | COM NEW | 15117B202 | 4,371,570 | 121,500 | SH | SOLE | 121,500 | 0 | 0 | ||
CELLDEX THERAPEUTICS INC | COM NEW | 99D2DH6V9 | 3,598,000 | 1,000 | SH | Put | SOLE | 1,000 | 0 | 0 | |
CYMABAY THERAPEUTICS INC. COMMON STOCK | COM | 23257D103 | 7,660,520 | 878,500 | SH | SOLE | 878,500 | 0 | 0 | ||
ENLIVEN THERAPEUTICS INC | COM | 29337E102 | 678,440 | 30,979 | SH | SOLE | 30,979 | 0 | 0 | ||
EYEPOINT PHARMACEUTICALS INC | COM NEW | 30233G209 | 891,984 | 303,396 | SH | SOLE | 303,396 | 0 | 0 | ||
GH RESEARCH PLC | ORDINARY SHARES | G3855L106 | 1,943,568 | 243,250 | SH | SOLE | 243,250 | 0 | 0 | ||
HILLEVAX INC | COM | 43157M102 | 110,156 | 6,664 | SH | SOLE | 6,664 | 0 | 0 | ||
HORIZON THERAPEUTICS PLC | SHS | G46188101 | 654,840 | 6,000 | SH | SOLE | 6,000 | 0 | 0 | ||
IOVANCE BIOTHERAPEUTICS INC | COM | 462260100 | 938,734 | 153,639 | SH | SOLE | 153,639 | 0 | 0 | ||
IVERIC BIO INC | COM | 99D2WLPZ9 | 3,649,500 | 1,500 | SH | Call | SOLE | 1,500 | 0 | 0 | |
IVERIC BIO INC | COM | 46583P102 | 6,824,565 | 280,500 | SH | SOLE | 280,500 | 0 | 0 | ||
KEROS THERAPEUTICS INC | COM | 492327101 | 152,653 | 3,575 | SH | SOLE | 3,575 | 0 | 0 | ||
KINNATE BIOPHARMA INC | COM | 49705R105 | 31,250 | 5,000 | SH | SOLE | 5,000 | 0 | 0 | ||
KURA ONCOLOGY INC. COMMON STOCK | COM | 50127T109 | 6,913,093 | 565,257 | SH | SOLE | 565,257 | 0 | 0 | ||
MERSANA THERAPEUTICS INC | COM | 59045L106 | 246,600 | 60,000 | SH | SOLE | 60,000 | 0 | 0 | ||
NUVATION BIO INC | *W EXP 07/07/2027 | 67080N119 | 10,900 | 90,832 | SH | SOLE | 90,832 | 0 | 0 | ||
PMV PHARMACEUTICALS INC | COM | 69353Y103 | 736,827 | 154,471 | SH | SOLE | 154,471 | 0 | 0 | ||
REZOLUTE INC | COM NEW | 76200L309 | 703,112 | 366,204 | SH | SOLE | 366,204 | 0 | 0 | ||
ROCKET PHARMACEUTICALS INC | COM | 77313F106 | 5,104,740 | 298,000 | SH | SOLE | 298,000 | 0 | 0 | ||
SAREPTA TEHRAPEUTICS INC | COM | 803607100 | 4,516,689 | 32,770 | SH | SOLE | 32,770 | 0 | 0 | ||
SAVARA INC | COM | 805111101 | 388,110 | 199,031 | SH | SOLE | 199,031 | 0 | 0 | ||
SYNDAX PHARMACEUTICALS INC | COM | 87164F105 | 6,969,600 | 330,000 | SH | SOLE | 330,000 | 0 | 0 | ||
TERNS PHARMACEUTICALS INC | COM | 880881107 | 13,015,819 | 1,099,309 | SH | SOLE | 1,099,309 | 0 | 0 | ||
UNITED THERAPEUTICS CORP DEL | COM | 91307C102 | 5,263,060 | 23,500 | SH | SOLE | 23,500 | 0 | 0 | ||
VAXCYTE INC | COM | 92243G108 | 4,516,340 | 120,500 | SH | SOLE | 120,500 | 0 | 0 | ||
VENTYX BIOSCIENCES INC | COM | 92332V107 | 6,984,750 | 208,500 | SH | SOLE | 208,500 | 0 | 0 | ||
VIKING THERAPEUTICS INC | COM | 92686J106 | 233,100 | 14,000 | SH | SOLE | 14,000 | 0 | 0 | ||
VIRIDIAN THERAPEUTICS INC | COM | 92790C104 | 4,273,920 | 168,000 | SH | SOLE | 168,000 | 0 | 0 |